P. Probst

发表

Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.

R. Coler, S. Reed, Joe D. Cohen, 2009, FEMS immunology and medical microbiology.

Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response.

P. Zipfel, B. Fleischer, P. Probst, 1996, Journal of immunology.

Identification and Characterization of T Cell-Stimulating Antigens from Leishmania by CD4 T Cell Expression Cloning1

S. Reed, R. Badaró, J. Webb, 2001, The Journal of Immunology.

CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis.

M. Starnbach, L. Steele, S. D’Orazio, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial

E. Muñoz-Elías, P. Probst, E. Tarcha, 2017, PloS one.

Monoclonal antibodies to surface antigens of a pathogenic Mycoplasma hominis strain

L. D. Olson, A. Karpas, M. Barile, 1991, Infection and immunity.

Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis.

R. Lahesmaa, T. Möttönen, E. Märker-Hermann, 1998, Arthritis and rheumatism.

Stimulation of synovial fluid mononuclear cells with the human 65‐kD heat shock protein or with live enterobacteria leads to preferential expansion of TCR‐γδ+ lymphocytes

A. Lohse, W. Eden, B. Fleischer, 1992 .

Genomic organization and DNA sequence of the human catecholamine-sulfating phenol sulfotransferase gene (STM).

P. Munroe, P. Probst, N. Doggett, 1994, Biochemical and biophysical research communications.

Synovial fluid‐derived Yersinia‐reactive T cells responding to human 65‐kDa heat‐shock protein and heat‐stressed antigen‐presenting cells

W. van Eden, A. Lohse, R. van der Zee, 1991, European journal of immunology.

Multiclonal synovial T cell response to Yersinia enterocolitica in reactive arthritis: the Yersinia 61-kDa heat-shock protein is not the major target antigen.

B. Fleischer, K. Meyer zum Büschenfelde, P. Probst, 1993, The Journal of infectious diseases.

Identification of the Yersinia enterocolitica urease beta subunit as a target antigen for human synovial T lymphocytes in reactive arthritis

First, B. Fleischer, K. Meyer zum Büschenfelde, 1993, Infection and immunity.

TLR4 agonists as immunomodulatory agents

M. Alderson, P. Mcgowan, P. Probst, 2006, Journal of endotoxin research.

A Leishmania protein that modulates interleukin (IL)‐12, IL‐10 and tumor necrosis factor‐α production and expression of B7‐1 in human monocyte‐derived antigen‐presenting cells

S. Reed, K. Grabstein, P. Probst, 1997, European journal of immunology.

Predominance of Th1‐type T cells in synovial fluid of patients with Yersinia‐induced reactive arthritis

B. Fleischer, H. Gallati, P. Probst, 1992, European journal of immunology.

Functional Characterization of Class Ia- and Non-Class Ia-Restricted Chlamydia-Reactive CD8+ T Cell Responses in Humans 1

J. Marrazzo, W. Stamm, K. Grabstein, 2003, The Journal of Immunology.

T Cell Responses in Humans + CD 8-Reactive Chlamydia Non-Class Ia-Restricted Functional Characterization of Class Ia-and Marrazzo

J. Marrazzo, W. Stamm, K. Grabstein, 2003 .

Mapping of two phenol sulphotransferase genes, STP and STM, to 16p: candidate genes for Batten disease.

P. Munroe, Z. Deng, M. Siciliano, 1994, Biochemical and biophysical research communications.

Role of bacteria-specific T cells in the immunopathogenesis of reactive arthritis.

B. Fleischer, P. Probst, E. Hermann, 1994, Trends in microbiology.

Chlamydial Antigens Colocalize within IncA-Laden Fibers Extending from the Inclusion Membrane into the Host Cytosol

D. Rockey, P. Probst, Y. Skeiky, 2002, Infection and Immunity.

TLR4 agonists as immunomodulatory agents.

M. Alderson, P. Mcgowan, P. Probst, 2006 .

Phenol sulfotransferases: candidate genes for Batten disease.

M. Siciliano, S. Mole, H. Mitchison, 1995, American journal of medical genetics.

A Synthetic TLR4 Antagonist Has Anti-Inflammatory Effects in Two Murine Models of Inflammatory Bowel Disease 1

D. Persing, R. Hershberg, R. Ulevitch, 2005, The Journal of Immunology.

Models of Inflammatory Bowel Disease Anti-Inflammatory Effects in Two Murine A Synthetic TLR 4 Antagonist Has Fling

D. Persing, R. Hershberg, R. Ulevitch, 2005 .

Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists*

D. Persing, R. Hershberg, R. Ulevitch, 2004, Journal of Biological Chemistry.

Human CD8+ T Cells Recognize the 60-kDa Cysteine-Rich Outer Membrane Protein from Chlamydia trachomatis1

S. Fling, K. Grabstein, M. Alderson, 2004, The Journal of Immunology.

Differential Regulation of Inflammatory Cytokine Secretion by Human Dendritic Cells upon Chlamydia trachomatis Infection

R. Suchland, K. Grabstein, M. Alderson, 2004, Infection and Immunity.

A Novel Highly Potent Therapeutic Antibody Neutralizes Multiple Human Chemokines and Mimics Viral Immune Modulation

Ryan L. Kelly, T. Foy, M. Scalley‐Kim, 2012, PloS one.

TH2-type infiltrating T cells in nickel-induced contact dermatitis.

B. Fleischer, P. Probst, D. Küntzlin, 1995, Cellular immunology.

A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.

M. Gale, Y. Loo, K. Bedard, 2017, Vaccine.